Coronary Artery Disease. We see you. RESULTS OF ANNUAL GENERAL MEETING PERTH, Australia, 13 November 2026: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology ® company commercialising its Salix AI-powered cloud platform, for the near real time, point of care assessment and...
Artrya: Results of Annual General Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Artrya Limited has released the results of its Annual General Meeting, where all resolutions were passed on a poll. The filing includes detailed voting results for each resolution considered at the meeting. The resolutions included the adoption of the remuneration report and the election of directors. The company is focused on developing AI-powered solutions for coronary artery disease management.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Artrya
- AGM Chairmans Address and CEO Presentation
- Five Yr Agreement with HonorHealth Expands US Momentum
- Ceasing to be a substantial holder
- Becoming a substantial holder
- Artrya 2026 Annual General Meeting - Webinar Details
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya